Literature DB >> 21328073

Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations.

A Stracciari1, E Baldin, L Cretella, L Delaj, R D'Alessandro, M Guarino.   

Abstract

Three cirrhotic patients with chronic acquired hepatocerebral degeneration (CAHD) received neurologic, neuropsychologic and neuroimaging assessment before and after liver transplantation (LT). Before transplantation, neurologic dysfunction consisted in severe bradykinesia, dystonia, dyskinesia, ataxia and dysarthria. Cognitive impairment affected mainly attentional and executive domains. Brain MRI showed bilateral hyperintensities of the basal ganglia on T1-weighted images. After transplantation, motor manifestations promptly resolved. Cognitive testing showed a major improvement in two patients, whereas cognitive performances were slightly worsened in the third, reasonably due to the effects of a head injury before LT and a tacrolimus-related encephalopathy arising early after LT. MRI images 12 months later showed a slight reduction of the previously disclosed abnormalities in all three patients. None of them experienced recurrence of CAHD. Our observation reinforces the assumption that surgery is the best treatment option for CAHD and that severe neurological impairment in CAHD should not be considered a contraindication for LT.

Entities:  

Mesh:

Year:  2011        PMID: 21328073     DOI: 10.1007/s10072-011-0481-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  17 in total

1.  Acquired hepatocerebral degeneration: full recovery after liver transplantation.

Authors:  A Stracciari; M Guarino; P Pazzaglia; G Marchesini; P Pisi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

2.  Speech disorder related to tacrolimus-induced pontine myelinolysis after orthotopic liver transplantation.

Authors:  Matteo Ravaioli; Maria Guarino; Andrea Stracciari; Gian Luca Grazi; Marco Pastore Trossello; Giorgio Ercolani; Antonino Cavallari
Journal:  Transpl Int       Date:  2003-06-18       Impact factor: 3.782

3.  Minimal hepatic encephalopathy: longitudinal effects of liver transplantation.

Authors:  Katia Mattarozzi; Andrea Stracciari; Luca Vignatelli; Roberto D'Alessandro; Maria Cristina Morelli; Maria Guarino
Journal:  Arch Neurol       Date:  2004-02

Review 4.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

5.  Hepatic dementia or acquired hepatocerebral degeneration.

Authors:  M F Mendez
Journal:  J Am Geriatr Soc       Date:  1989-03       Impact factor: 5.562

6.  Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD).

Authors:  Spiridon Papapetropoulos; Carlos Singer
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

7.  Effect of liver transplantation on neurological manifestations in Wilson disease.

Authors:  A Stracciari; A Tempestini; A Borghi; M Guarino
Journal:  Arch Neurol       Date:  2000-03

8.  Acquired hepatocerebral degeneration: MR and pathologic findings.

Authors:  J Lee; D Lacomis; S Comu; J Jacobsohn; E Kanal
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

9.  Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

Authors:  Binnur Pinarbasi; Sabahattin Kaymakoglu; Zeliha Matur; Filiz Akyuz; Kadir Demir; Fatih Besisik; Sadakat Ozdil; Gungor Boztas; Yilmaz Cakaloglu; Zeynel Mungan; Atilla Okten
Journal:  J Clin Gastroenterol       Date:  2009-02       Impact factor: 3.062

10.  Cognitive functioning in chronic acquired hepatocerebral degeneration.

Authors:  Andrea Stracciari; Katia Mattarozzi; Roberto D'Alessandro; Elisa Baldin; Maria Guarino
Journal:  Metab Brain Dis       Date:  2008-04-24       Impact factor: 3.584

View more
  9 in total

Review 1.  Neurologic complications after liver transplantation.

Authors:  Saša A Zivković
Journal:  World J Hepatol       Date:  2013-08-27

2.  Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients.

Authors:  Elisa Maffeo; Anna Montuschi; Guido Stura; Maria Teresa Giordana
Journal:  Neurol Sci       Date:  2013-05-28       Impact factor: 3.307

Review 3.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

4.  Chronic acquired hepatocerebral degeneration presenting with Meige's syndrome and behavioral symptoms fully reversed by liver transplantation.

Authors:  Andrea Stracciari; Luca Spinardi; Maria Guarino
Journal:  Neurol Sci       Date:  2021-07-19       Impact factor: 3.307

Review 5.  Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2012-10-20       Impact factor: 3.584

6.  Hepatic encephalopathy coexists with acquired chronic hepatocerebral degeneration.

Authors:  Feng-Zhen Huang; Xuan Hou; Tie-Qiao Zhou; Si Chen
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

7.  A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis.

Authors:  Diana Apetauerova; Peter Hildebrand; Stephanie Scala; Janet W Zani; LeeAnne Lipert; Erin Clark; Tanya Fennell; Fredric D Gordon
Journal:  Hepatol Commun       Date:  2020-11-26

8.  Acquired hepatocerebral degeneration.

Authors:  Destina Yalcin; Emel Oguz-Akarsu; Mehmet Sokmen
Journal:  Neurosciences (Riyadh)       Date:  2016-04       Impact factor: 0.906

Review 9.  Recent Updates on Acquired Hepatocerebral Degeneration.

Authors:  Hae-Won Shin; Hee Kyung Park
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.